Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:22 PM
Ignite Modification Date:
2025-12-24 @ 4:22 PM
NCT ID:
NCT06321666
Eligibility Criteria:
Inclusion Criteria:
* Histological diagnosis of breast cancer
* Single or multiple bone metastases (additional extraosseous or non-bony metastatic disease permitted)
* Due to start a new line of either hormone therapy or chemotherapy (use of bisphosphonates / denosumab or targeted agents e.g. trastuzumab in addition to hormone therapy / chemotherapy permitted)
* Aged 18 and over
* Life expectancy of over 6 months
* No current active malignancy other than breast cancer
Exclusion Criteria:
* Radical treatment to sole site of metastatic disease e.g. Cyberknife to solitary bone metastasis
* Absolute contraindication to MRI studies, CT scans, bone scans or FDG-PET/CT
* Pregnancy
* Psychological, familial, sociological or geographical conditions that would hamper compliance with the study protocol; such conditions should be discussed with the patient as part of the informed consent process.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06321666
Study Brief:
Protocol Section:
NCT06321666